Natco Pharma Ltd
Satya Narayana Rao has extensive experience in pharmaceutical production, currently serving as AGM Production at NATCO Pharma since May 2022. Previously, Satya held the same position at Optimus Pharma from December 2017 to May 2022 and served as Senior Manager at Vivimed Labs Ltd from September 2015 to December 2017. Satya's career also includes several roles at Zenara Pharma Ltd, Hetero Drugs Ltd, Alembic Pharmaceuticals Limited, and V.V.S Pharmaceuticals Pvt. Ltd, progressing from Production Chemist to Executive Production and various managerial positions. With a Bachelor’s Degree in Pharmacy from Karnataka College obtained in 1999, Satya specializes in manufacturing, packing, and dispatch processes, as well as planning and inventory management for pharmaceutical formulations, including Anti Retro Viral products.
This person is not in any teams
This person is not in any offices
Natco Pharma Ltd
2 followers
Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate. The Company manufactures over 20 products under contract.